Internal Medicine, Hematology & Oncology · Richmond, VA
NPI
1205132107
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1250 E Marshall St, Internal Medicine
Richmond, VA, 23298
Phone (804) 828-7999
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
305 services
Medicare patients, 2024
110
Average age 72
Drug cost, 2024
$693K
105 prescriptions
Company payments, 2025
$740
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sosipatros Boikos was code 99215 (office e&m - established), 209 times for 59 patients. In total Sosipatros Boikos billed 305 services in 8 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 209 | 59 | $119.74 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 57 | 40 | $106.99 | $6,099 |
By year: 2022 $31K for 285 services; 2023 $48K for 429 services; 2024 $36K for 305 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sosipatros Boikos prescribed most often to Medicare patients was Imatinib Mesylate, with 11 prescriptions and refills. In total Sosipatros Boikos wrote 105 Medicare prescriptions that cost $693K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 11 | 11 | Under 11 | $23K |
| Tazverik Tazemetostat Hydrobromide | 11 | 11 | Under 11 | $222K |
Brand drugs: 34 claims; generic drugs: 71 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sosipatros Boikos $740 ($740 in general payments such as food, travel and fees) from 1 company. The largest payer was Caris MPI, Inc. with $740.
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 3 | $740 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.